H1FY24 Results - Investor Presentation slide image

H1FY24 Results - Investor Presentation

Financial Overview (Reported) | H1FY24 Performance summary - P&L P&L (RM' mil) Q1FY24 Q2FY24 QoQ Change H1FY231 H1FY24 YoY Change Total Income 1,202 1,124 (7%) 2,329 2,326 22 NII 809 846 5% 1,787 1,654 (7%) NOII 393 278 (29%) 542 671 24% MFRS 17 restatement impact (17) Expenses (508) (493) (3%) (1,047) (1,000) (4%) PBP 694 631 (9%) 1,282 1,325 3% Net Impairment PBT (190) (13) (93%) (267) (204) (24%) 504 618 23% 1,015 1,122 11% PAT 403 470 16% 778 873 12% -Profit from Continuing Operations² 352 470 33% 844 822 (3%) - Profit from Discontinued Operation³ PATMI 51 N/A (66) 51 >100% 378 470 24% 837 848 1% - PATMI from Continuing Operations² -PATMI from Discontinued Operation³ 352 470 33% 844 822 (3%) 26 N/A (7) 26 >100% Financial Indicators Q1FY24 Q2FY24 QoQ Change H1FY231 H1FY24 YoY Change CTI 42.2% 43.8% 1.6% 45.0% 43.0% (2.0%) NIM 1.76% 1.82% 0.06% 2.17% 1.79% (0.38%) ROE (Annualised) 8.3% 10.1% 1.8% 9.9% 9.3% (0.6%) Basic EPS (sen)4 11.44 14.20 24.1% 25.29 25.65 1.4% Net Assets per Share (RM)5 5.59 5.60 0.1% 5.19 5.60 7.9% 1. H1FY23 P&L numbers are restated following the adoption of MFRS 17 for Insurance Business 2. 3. 4. Continuing operations comprised Banking operations and Insurance. Insurance mainly consists of Life Insurance (as JV) and General Insurance (as associate from August'22 onwards) Discontinued operation in H1FY23 and Q1FY24/H1FY24 comprised General Insurance as subsidiary from April'22 to July'22 and RM51m gain from AmGen divestment completion respectively Computed based on weighted average number of shares 5. Computed based on number of ordinary shares issued at period end (excludes treasury shares) AmBank Group H1FY24 Results - Investor Presentation 9
View entire presentation